Artificial neural network accurately predicts hepatitis B surface antigen seroclearance.
<h4>Background & aims</h4>Hepatitis B surface antigen (HBsAg) seroclearance and seroconversion are regarded as favorable outcomes of chronic hepatitis B (CHB). This study aimed to develop artificial neural networks (ANNs) that could accurately predict HBsAg seroclearance or seroconve...
Saved in:
| Main Authors: | Ming-Hua Zheng, Wai-Kay Seto, Ke-Qing Shi, Danny Ka-Ho Wong, James Fung, Ivan Fan-Ngai Hung, Daniel Yee-Tak Fong, John Chi-Hang Yuen, Teresa Tong, Ching-Lung Lai, Man-Fung Yuen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0099422&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mechanisms of hepatocellular carcinoma and cirrhosis development in concurrent steatotic liver disease and chronic hepatitis B
by: Saisai Zhang, et al.
Published: (2025-02-01) -
Prospect of emerging treatments for hepatitis B virus functional cure
by: Rex Wan-Hin Hui, et al.
Published: (2025-02-01) -
Longitudinal profile of plasma pregenomic RNA in patients with chronic hepatitis B infection on long-term nucleoside analogues and its interaction with clinical parameters
by: Lung-Yi Mak, et al.
Published: (2025-04-01) -
Mechanisms underlying delayed loss of HBeAg and HBV DNA following HBsAg seroclearance in PEG-IFNα treated patients of chronic hepatitis B
by: Bei Jiang, et al.
Published: (2025-12-01) -
Glucagon-like peptide 1 receptor agonist and reduced liver and non-liver complications in adults with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease: a target trial emulation study
by: Xianhua Mao, et al.
Published: (2025-07-01)